DB
AMRX icon

Danske Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Danske Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-109,121
Closed -$1.09M – 1571
2025
Q3 		$1.09M Sell
109,121
-42,565
-28% -$382K ﹤0.01% 665
2025
Q2 		$1.23M Sell
151,686
-33,617
-18% -$253K ﹤0.01% 691
2025
Q1 		$1.55M Buy
185,303
+7,894
+4% +$65.9K ﹤0.01% 739
2024
Q4 		$1.41M Buy
177,409
+51,253
+41% +$430K ﹤0.01% 799
2024
Q3 		$1.05M Buy
+126,156
New +$987K ﹤0.01% 804

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Danske Bank's AMRX Position: Q4 2025 in Review

Danske Bank sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 109,121 shares — an estimated $1.09M sold.

Danske Bank first reported a position in AMRX in Q3 2024 and held it in 5 quarters. The position peaked at $1.55M in Q1 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Danske Bank reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Danske Bank sold 109,121 Amneal Pharmaceuticals shares in Q4 2025, an estimated $1.09M.
  • Danske Bank first reported a position in Amneal Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Danske Bank's Amneal Pharmaceuticals position peaked at $1.55M in Q1 2025.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Danske Bank's 13F filing for Q4 2025, filed 2 Feb 2026.